Back

Experts in dermatology focus on how new and advanced treatments are impacting the quality of life for individuals with atopic dermatitis (AD). They explore how to optimize the patient experience by utilizing these therapies in a strategic matter.

Improving Quality of Life in Atopic Dermatitis With Targeted Therapies

Episodes

Specialty:

All

Year:

All

EP. 1: An Overview of Atopic Dermatitis (AD)

ByLinda Stein Gold, MD,Matthew Zirwas, MD,Peter Lio, MD ,Alexandra K. Golant, MD,Aaron S. Farberg, MD

April 14th 2023

Peter A. Lio, MD, provides an overview of the pathophysiology of atopic dermatitis (AD) and the comorbidities often associated with it.

EP. 2: The Impact of Atopic Dermatitis on Quality of Life

ByLinda Stein Gold, MD,Matthew Zirwas, MD,Peter Lio, MD ,Alexandra K. Golant, MD,Aaron S. Farberg, MD

April 14th 2023

Expert dermatologists review the impact of atopic dermatitis on quality of life for both the patient and their families.

EP. 3: Treatment Landscape in Atopic Dermatitis

ByLinda Stein Gold, MD,Matthew Zirwas, MD,Peter Lio, MD ,Alexandra K. Golant, MD,Aaron S. Farberg, MD

April 21st 2023

Matthew Zirwas, MD, highlights therapies that are available for the treatment of atopic dermatitis, including corticosteroids, calcineurin inhibitors and JAK inhibitors.

EP. 4: Traditional Steroids vs Emerging Therapies in Atopic Dermatitis

ByLinda Stein Gold, MD,Matthew Zirwas, MD,Peter Lio, MD ,Alexandra K. Golant, MD,Aaron S. Farberg, MD

April 21st 2023

Alexandra Golant, MD, comments on the adverse events of systemic therapies and how emerging nonsteroidal agents have a better safety profile in atopic dermatitis.

EP. 5: Treatment Approach to Atopic Dermatitis

ByLinda Stein Gold, MD,Matthew Zirwas, MD,Peter Lio, MD ,Alexandra K. Golant, MD,Aaron S. Farberg, MD

April 28th 2023

Aaron S. Farberg, MD, discusses how new therapies have impacted his approach to treatment of atopic dermatitis.

EP. 6: Assessing Severity of Atopic Dermatitis

ByLinda Stein Gold, MD,Matthew Zirwas, MD,Peter Lio, MD ,Alexandra K. Golant, MD,Aaron S. Farberg, MD

April 28th 2023

Experts in dermatology consider the use of the Atopic Dermatitis Control Tool and other tools to assess severity of atopic dermatitis.

EP. 7: Overview of JAK Inhibitors in Atopic Dermatitis

ByLinda Stein Gold, MD,Matthew Zirwas, MD,Peter Lio, MD ,Alexandra K. Golant, MD,Aaron S. Farberg, MD

May 5th 2023

Peter A. Lio, MD, provides an overview of emerging JAK inhibitors in the treatment of atopic dermatitis.

EP. 8: Clinical Trials of Topical Ruxolitinib in Atopic Dermatitis

ByLinda Stein Gold, MD,Matthew Zirwas, MD,Peter Lio, MD ,Alexandra K. Golant, MD,Aaron S. Farberg, MD

May 5th 2023

Alexandra Golant, MD, highlights the positive clinical data of ruxolitinib, a topical JAK inhibitor used for the treatment of atopic dermatitis.

EP. 9: Safety Profile of Topical Ruxolitinib in Atopic Dermatitis

ByLinda Stein Gold, MD,Matthew Zirwas, MD,Peter Lio, MD ,Aaron S. Farberg, MD,Alexandra K. Golant, MD

May 12th 2023

Expert dermatologists review the safety data of topical ruxolitinib in the treatment of atopic dermatitis.

EP. 10: Ideal Candidates for Ruxolitinib Treatment of Atopic Dermatitis

ByLinda Stein Gold, MD,Matthew Zirwas, MD,Peter Lio, MD ,Alexandra K. Golant, MD,Aaron S. Farberg, MD

May 12th 2023

Matthew Zirwas, MD, provides insight into the ideal candidates for use of ruxolitinib to treat atopic dermatitis, focusing on patients with sensitive skin.

EP. 11: Efficacy and Reported Outcomes With JAK Inhibitors in Atopic Dermatitis

ByLinda Stein Gold, MD,Matthew Zirwas, MD,Peter Lio, MD ,Alexandra K. Golant, MD,Aaron S. Farberg, MD

May 19th 2023

Experts in dermatology discuss efficacy and patient-reported outcomes of topical and systemic JAK inhibitors and dosing guidelines in atopic dermatitis.